Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
53 | N-linked (GlcNAc...) asparagine | |||
86 |
|
|
||
130 | N-linked (GlcNAc...) asparagine | |||
161 |
|
|
||
396 | N-linked (GlcNAc...) asparagine |
|
||
576 |
|
|
||
580 | N-linked (GlcNAc...) asparagine | |||
592 |
|
|
||
|
|
Pathway Name | Organism |
---|---|
Biosynthesis of DHA-derived SPMs | Homo sapiens |
Biosynthesis of DPAn-3 SPMs | Homo sapiens |
Biosynthesis of EPA-derived SPMs | Homo sapiens |
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | Homo sapiens |
Interleukin-10 signaling | Homo sapiens |
Interleukin-4 and Interleukin-13 signaling | Homo sapiens |
Nicotinamide salvaging | Homo sapiens |
Synthesis of 15-eicosatetraenoic acid derivatives | Homo sapiens |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110193 | Charcot-Marie-Tooth disease type 4F | |
DOID:0110194 | Charcot-Marie-Tooth disease type 4B3 | |
DOID:0110195 | Charcot-Marie-Tooth disease type 4E | |
DOID:0110196 | Charcot-Marie-Tooth disease type 4G | |
DOID:0110197 | Charcot-Marie-Tooth disease dominant intermediate B | |
DOID:0110198 | Charcot-Marie-Tooth disease recessive intermediate C | |
DOID:0110199 | Charcot-Marie-Tooth disease dominant intermediate C | |
DOID:0110200 | Charcot-Marie-Tooth disease dominant intermediate D | |
DOID:0110202 | Charcot-Marie-Tooth disease dominant intermediate A | |
DOID:0110203 | Charcot-Marie-Tooth disease recessive intermediate D |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024